Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
We have been informed by our Registrars and Share Transfer Agent, KFin Technologies Private Limited about the issue of duplicate share certificates as detailed in the attachment. We request you to take the same on record. Procter & Gamble Health Ltd - 500126 - Certificate Under Regulation 40(9) Of The SEBI Listing Regulations For The Period Ended December 31, 2020
With reference to the above we are enclosing herewith Certificate under Regulation 40(9) of the SEBI Listing Regulations for the period ended December 31, 2020. Procter & Gamble Health Ltd - 500126 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
With reference to above captioned subject, we are enclosing herewith Certificate under Regulation 74(5) SEBI (Depositories and Participants) Regulations, 2018 for the period October - December 2020. Procter & Gamble Health Ltd - 500126 - Shareholding for the Period Ended December 31, 2020
Procter & Gamble Health Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here Procter & Gamble Health Ltd - 500126 - Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Flavia MachadoDesignation :- Any Other Procter & Gamble Health Ltd - 500126 - Board Meeting Intimation for Considering And Approving The Unaudited Financial Results For The Quarter Ended December 31, 2020
Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2021 ,inter alia, to consider and approve the unaudited financial results for the quarter ended December 31, 2020. Procter & Gamble Health Ltd - 500126 - Closure of Trading Window
We would like to inform you that the Trading Window of the Company shall remain closed for Directors and designated employees from January 1, 2021 until 48 hours from the publication of the unaudited financial results for quarter ended December 31, 2020. Kindly take the same on record.
COVID-19 update | Drugmaker Merck divests stake in vaccine-maker Moderna
Moderna is one of the front-runners in the race to develop a coronavirus vaccine, and on Monday filed for U.S. emergency use authorization of its vaccine. Procter & Gamble Health Ltd - 500126 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Procter & Gamble Health Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Procter & Gamble Health Ltd - 500126 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
We would like to inform you that the 53rd Annual General Meeting of the Company was held on November 26, 2020 at 3.30 p.m. through Video Conference / Other Audio Visual Means. In this respect, please find enclosed below: 1. Voting results in respect of the business conducted at the Annual General Meeting, as required under Regulation 44 (3) of the SEBI (Listing Obligations & Disclosure Requirements), Regulations, 2015; and 2. Scrutinizer's Report Kindly take the above on record and oblige.